USMLE® Step 1 style questions USMLE
USMLE® Step 2 style questions USMLE
A 68-year-old woman comes to the office for a routine examination. At this visit, she is diagnosed with mild hypertension and her physician elects to start treatment with a beta-blocker. The patients medical history includes asthma, for which she takes an albuterol inhaler as necessary, though she has not used it in over three years. Which of the following beta blockers is most likely to cause an exacerbation of her asthma?
Content Reviewers:Rishi Desai, MD, MPH
People with asthma can have asthma exacerbation or asthma attacks, which are usually triggered by something in the environment which causes immune cells to generate inflammation in the lungs which can make them even narrower and potentially be life-threatening.
In the bronchioles you’ve got the lumen, the mucosa, which includes the inner lining of epithelial cells, as well as the lamina propria, and the submucosa which is where the smooth muscle lives.
The molecular pathway that leads to asthma is actually pretty complex but it is often initiated by an environmental trigger.
What can happen with asthma is allergens from environmental triggers, like cigarette smoke, are picked up by dendritic cells which present them to a Th2 cell which produce cytokines like IL-4 and IL-5 leading to a number of features of asthma.
For example IL-4 leads the production of IgE antibodies which coat mast cells and stimulate them to release granules containing things like histamines, leukotrienes and prostaglandins. IL-5, on the other hand, activates eosinophils which promote an immune response by releasing more cytokines and leukotrienes.
In this case, since IgE antibodies are being produced this is an example of a Type 1 hypersensitivity reaction.n
This leads to two series of events. Early on, minutes after the exposure to the allergen, smooth muscle around the bronchioles start to spasms and there is increased mucus secretion.
This narrows the airways making it difficult to breathe, and this is why asthma is considered to be a type of obstructive pulmonary disease.
There is also an increase in vascular permeability and and recruitment of additional immune cells from the blood.
So, a few hours after exposure, these immune cells, particularly eosinophils, release chemical mediators that physically damage the endothelium of the lungs.
Initially these inflammatory changes are completely reversible, but over the years irreversible changes start to take place—edema, scarring, and fibrosis build up, leading to thickening of the epithelial basement membrane, which permanently reduces the airway diameter.
Although the specific causes of asthma are ultimately unknown, it’s thought to be caused by a combination of genetic and environmental factors, since certain genes have been identified that increase the risk of developing asthma and having a family history of asthma seems to increase risk as well.
For environmental factors, there’s the hygiene hypothesis, which suggests that reduced early immune-system exposure to bacteria and viruses which might actually increase the risk of later developing asthma, possibly by altering the overall proportion of immune cell subtypes.
- "Robbins Basic Pathology" Elsevier (2017)
- "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
- "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
- "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
- "Asthma-related comorbidities" Expert Review of Respiratory Medicine (2011)
- "Genes, environments, development and asthma: a reappraisal" European Respiratory Journal (2006)
- "Asthma: Clinical expression and molecular mechanisms" Journal of Allergy and Clinical Immunology (2010)